Biological Effects of Bacitracin as a Therapeutic Agent and Growth-Promoting Compound

Dr David Francis of South Dakota State University and director of the Center for Infectious Disease Research and Vaccinology describes an experiment in which he and co-workers found that cultivation of a wide variety of E. coli and Salmonella strains in the presence of sub-inhibitory concentrations of bacitracin favoured selection of tetracycline-sensitive organisms over those resistant to tetracycline. The paper was presented at Alpharma's Swine Enteric Health Symposium in 2008.
calendar icon 3 February 2009
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.